Established in 1911, the University’s vision is to create the next generation of global leaders through experience-rich education and world-leading, trustworthy research.
UWA consistently ranks in the top 1% of the world’s universities. Based in Perth, Western Australia, UWA benefits from vital research funding which enables them to translate our research into tangible benefits for Australia and the world.
UWA attracts the highest level of research income of any Western Australian university with the majority all national competitive funding to the state coming to UWA. In 2010, an independent study of the value of The University of Western Australia to the state economy – undertaken by ACIL-Tasman – estimated that in the next 40 years, UWA would contribute more than $60 billion dollars value to the Western Australian community through its research programs, educational functions, capabilities, relationships and investments. Our researchers tackle global, regional and local issues to make the world a better place. Their research translates into economic, social and environmental impact.
The University of Western Australia (UWA) recently launched ROAP (Research Online Application Portal) powered by F1 Solutions’ OmniStar Research providing a single, contemporary solution to manage their ethics applications and research grants.
Research grants, along with animal ethics, human ethics and biosafety applications are managed through ROAP. The system facilitates the effective, streamlined and transparent administration of research projects, including research administration management, and compliance
management. In addition, processes have been simplified and been made more efficient through the removal of paper forms and automated sign off.
ROAP will provide researchers, committee members and approvers with up-to-date information regarding the status of all applications in real-time. Streamlined online application and electronic approval processes mean more time for researchers to do what they do best while providing substantial staff resource capacity savings and a better user experience for every stakeholder.
The benefits of ROAP:
UWA continues to make significant investment into major research infrastructure to establish, across all disciplines, a network of world-class platforms and technologies that underpin their research effort and attract the brightest minds on the planet. These facilities build critical mass, support research collaborations both internal and external and help develop new partnerships, including with industry.
F1 Solutions is proud to support research excellence as UWA endeavors to be world leaders in cutting-edge research.
The ARMS Executive is pleased to announce that Australian-based software development company, F1 Solutions has joined forces with our Society to become a Platinum Corporate Partner.
F1 Solutions is passionate about the research management profession and sees this collaboration with ARMS as a natural fit and an exciting opportunity.
F1 Solutions has built a number of leading software solutions, including OmniStar Research, a research management system that manages every stage of the research life-cycle. OmniStar Research is unlike anything else on the market. It is at the leading edge of software systems to manage research governance, ethics review, grant and contract management and much more.
Belonging to the OmniStar product suite, OmniStar Research is an out-of-the-box solution with a difference. There are over 500 features you can configure to meet the specific needs of your organisation. Unlike the traditional approach, OmniStar Research empowers users to implement processes that suit them best. This combination of adaptability and simplicity is saving organisations money and increasing operational efficiency.
ARMS PRESIDENT, MS JANICE BESCH SAID:
“Our Gold Corporate Partners are important to us and we are thrilled to have another fabulous friend of the research management profession on board. Gold Partners are with us on every step of our journey, helping us deliver across communications, large and small scale events, and advocacy and publications activities. Through its valued support, Australian based software development company, F1 Solutions, extends our reach to deliver new opportunities across the membership while at the same time reminding us of the essential role that research management systems play in our world.”
GUS BOMAN, FOUNDING DIRECTOR OF F1 SOLUTIONS SAID:
“We are extremely excited to be partnering with ARMS as a Gold Corporate Partner. This partnership demonstrates our commitment to the research management industry, and our genuine endeavour to help the industry grow, transform and thrive in an ever changing environment. Our Research Management System, OmniStar Research, is testament to that. We look forward to connecting with many of you over the coming months and at the INORMS conferences.”
For further details please contact Maria Zollo, Chief Operating Officer of ARMS or Gus Boman, Founding Director of F1 Solutions.
Dr. Gordon McGurk of National Health and Medical Research Council (NHMRC), gave a talk at INORMS 2016 Business Breakfast about Ethics Review in Australia.
He discussed the efforts that NHMRC is undertaking to streamline ethics review. Part of that initiative is the new Human Research Ethics Application (HREA) form that replaces the outdated NEAF (National Ethics Application Form).
Download a copy below of Dr McGurk’s (Clinical Trials Director) presentation.
MyResearch is a researcher centric Research Management System that is purpose-built to deliver efficiencies across the board.
MyResearch facilitates the effective, streamlined and transparent administration of research projects, including research administration management, and compliance management. The solution also supports integration with core UQ systems and enables a holistic view of research project management, administration and compliance across the entire research lifecycle.
MyResearch enables individual researchers and research administrators to have direct access to key research project information in real-time, facilitating research administration and compliance management. Streamlined online application and electronic approval processes means more time for researchers to do what they do best while providing substantial staff resource capacity savings and a better user experience for every stakeholder.
The benefits of MyResearch:
OmniStar, which powers MyResearch is a purpose built, software-as-a-service platform incorporating the very latest principles, practices and standards for grants, ethics and research management. It has been developed over almost two decades of consultation with many of leading research and grants institutions and now powers such institutions as The University of Western Australia, National Health and Medical Research Council and most recently, South Australia Health.
OmniStar Ethics, the platform for NSW Health’s Research Ethics and Governance Information System (REGIS)
F1 Solutions has been awarded the contract to build NSW Health’s research ethics compliance and governance management system. The REGIS program will be delivered on F1 Solutions Software as a Service (SaaS) platform, OmniStar Ethics. OmniStar Ethics is a member of F1 Solutions OmniStar product suite which also includes OmniStar Grants and OmniStar Research. Our suite of OmniStar products, offers exceptional architecture that satisfies a range of business needs as the features are able to be mixed and matched via configuration across the entire product family.
REGIS’s implementation is slated for late-2017, and will replace the existing Australian Research Ethics Database (AU RED) and Online Forms across all NSW Public Health Organisations (PHO). Our OmniEthics platform simplifies research ethics management at every stage of the process and REGIS is expected to be able to manage multi-site projects as well as those involving National Mutual Acceptance (NMA).
Gustad Boman, Director F1 Solutions, says, “NSW Health should be commended for selecting a solution that gives them the platform for taking on the leadership position in attracting clinical research investment in NSW. Best of all it is an Australian product and solution, which means the economic and upskilling benefits remain in Australia.”